The Alport Syndrome Foundation, Inc. (ASF), Pedersen Family and the Kidney Foundation of Canada (KFOC) are pleased to announce the availability of funding for research to find novel treatments to prevent kidney failure and hearing loss in all patients with Alport Syndrome.
Types of Proposals Sought
Research proposals with the potential to accelerate the development of new treatments to prolong kidney function and prevent hearing loss including:
- Identification and investigation of target pathways in disease progression
- Drug repurposing of existing approved drugs or other new approaches to improve the current standard of care.
There are no geographical limitations of this funding. Only applications in English will be accepted.
It is anticipated that two research projects will be selected for funding, totaling $100,000 USD each, over a one- to two-year time frame. Successful applicants will be notified in June 2017 in accordance with the ASF, Pedersen Family, KFOC Alport Syndrome Research Funding Program.
Research proposals will be evaluated by an independent peer review process. Applications should be of 10–15 pages in length and must be in accordance with the instructions in the ASF, Pedersen Family, KFOC Alport Syndrome Research Funding Program.
The deadline for submission of completed research funding applications is Monday, March 20, 2017 by 5:00 pm Arizona Time/MST (no late submittals will be accepted).
For more information about the ASF Research Program, click here.